Germline variants of genes with high penetrance mutations for prostate cancer susceptibility, including HOXB13, BRCA1/2, and DNA mismatch repair genes, account for about another 5% of prostate cancer risk 10, 11. This evidence concerns the gene BRCA1 and prostate carcinoma.